(Q54329995)
Statements
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02). (English)
S Schmitz
M-C Kaminsky-Forrett
S Henry
S Zanetta
L Geoffrois
E Bompas
A Moxhon
L Mignion
J Guigay
L Knoops
J-P Machiels
10 January 2012
23
8
2153-2161